Newly engineered protein could be used to develop adaptation-proof COVID vaccine

A vaccine design approach that could protect against new variants of SARS-CoV-2 — the virus that causes COVID-19 — but also potentially protects against other coronaviruses is one step closer to reality as a result of research at Penn State College of Medicine. The scientists used areas of the SARS-CoV-2 virus that are less susceptible to mutation to engineer proteins called immunogens, which can elicit an immune response.

Related Keywords

Suresh Kuchipudi ,Abhinay Gontu ,Brendan Rackley ,Morgan Chandler ,Kirill Afonin ,G Thomas Passananti ,Yashavantha Vishweshwaraiah ,Neil Christensen ,Brianna Hnath ,Jian Wang ,Nikolay Dokholyan ,Centers For Disease ,University Of North Carolina At Charlotte ,National Institutes Of Health ,Penn State College Of Medicine ,Passan Foundation ,Department Of Pharmacology ,Huck Institutes Of The Life Sciences ,Penn State College ,Passananti Professor ,Disease Control ,Advanced Functional Materials ,Neela Yennawar ,Penn State Huck Institutes ,Life Sciences ,North Carolina ,Huck Institutes ,National Institutes ,